001     128462
005     20240228135100.0
024 7 _ |a 10.1371/journal.pone.0109682
|2 doi
024 7 _ |a pmid:25289670
|2 pmid
024 7 _ |a pmc:PMC4188809
|2 pmc
024 7 _ |a altmetric:4916260
|2 altmetric
037 _ _ |a DKFZ-2017-04478
041 _ _ |a eng
082 _ _ |a 500
100 1 _ |a Usenko, Tatiana
|b 0
245 _ _ |a Leukemogenic Ptpn11 allele causes defective erythropoiesis in mice.
260 _ _ |a Lawrence, Kan.
|c 2014
|b PLoS
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1521200609_30036
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Src homology 2 (SH2) domain-containing phosphatase 2 (SHP2), encoded by PTPN11, regulates signaling networks and cell fate in many tissues. Expression of oncogenic PTPN11 in the hematopoietic compartment causes myeloproliferative neoplasm (MPN) in humans and mice. However, the stage-specific effect(s) of mutant Ptpn11 on erythroid development have remained unknown. We found that expression of an activated, leukemogenic Ptpn11 allele, Ptpn11D61Y, specifically in the erythroid lineage causes dyserythropoiesis in mice. Ptpn11D61Y progenitors produce excess cKIT+ CD71+ Ter119- cells and aberrant numbers of cKITl° CD71+ erythroblasts. Mutant erythroblasts show elevated activation of ERK, AKT and STAT3 in response to EPO stimulation, and MEK inhibitor treatment blocks Ptpn11D61Y-evoked erythroid hyperproliferation in vitro. Thus, the expression of oncogenic Ptpn11 causes dyserythropoiesis in a cell-autonomous manner in vivo.
536 _ _ |a 311 - Signalling pathways, cell and tumor biology (POF3-311)
|0 G:(DE-HGF)POF3-311
|c POF3-311
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Antigens, CD
|2 NLM Chemicals
650 _ 7 |a Butadienes
|2 NLM Chemicals
650 _ 7 |a CD71 antigen
|2 NLM Chemicals
650 _ 7 |a Nitriles
|2 NLM Chemicals
650 _ 7 |a Protein Kinase Inhibitors
|2 NLM Chemicals
650 _ 7 |a Receptors, Transferrin
|2 NLM Chemicals
650 _ 7 |a STAT3 Transcription Factor
|2 NLM Chemicals
650 _ 7 |a Stat3 protein, mouse
|2 NLM Chemicals
650 _ 7 |a U 0126
|2 NLM Chemicals
650 _ 7 |a Erythropoietin
|0 11096-26-7
|2 NLM Chemicals
650 _ 7 |a Proto-Oncogene Proteins c-kit
|0 EC 2.7.10.1
|2 NLM Chemicals
650 _ 7 |a Proto-Oncogene Proteins c-akt
|0 EC 2.7.11.1
|2 NLM Chemicals
650 _ 7 |a Extracellular Signal-Regulated MAP Kinases
|0 EC 2.7.11.24
|2 NLM Chemicals
650 _ 7 |a Protein Tyrosine Phosphatase, Non-Receptor Type 11
|0 EC 3.1.3.48
|2 NLM Chemicals
650 _ 7 |a Ptpn11 protein, mouse
|0 EC 3.1.3.48
|2 NLM Chemicals
700 1 _ |a Chan, Gordon
|b 1
700 1 _ |a Torlakovic, Emina
|b 2
700 1 _ |a Klingmüller, Ursula
|0 P:(DE-He78)860df4ab16c373fb28a815dcd81107a6
|b 3
|u dkfz
700 1 _ |a Neel, Benjamin G
|b 4
773 _ _ |a 10.1371/journal.pone.0109682
|g Vol. 9, no. 10, p. e109682 -
|0 PERI:(DE-600)2267670-3
|n 10
|p e109682 -
|t PLoS one
|v 9
|y 2014
|x 1932-6203
909 C O |o oai:inrepo02.dkfz.de:128462
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)860df4ab16c373fb28a815dcd81107a6
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-311
|2 G:(DE-HGF)POF3-300
|v Signalling pathways, cell and tumor biology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2014
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PLOS ONE : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)A150-20160331
|k A150
|l Systembiologie der Signaltransduktion
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A150-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21